Jeffrey W. Albers - Director at Kymera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
KYMR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Jeffrey W. Albers - trading volume in the past year for Kymera Therapeutics, Inc.

Holdings reported by Jeffrey W. Albers for Kymera Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $90.30 Dec 8, 2025 Direct
Stock Option (Right to Buy) 7K Dec 8, 2025 Direct Common Stock

Transactions reported by Jeffrey W. Albers for Kymera Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.